Insights into osteosarcoma in cats and dogs may improve palliative care
... The research team, which included U. of I. pathobiology professor Anne Barger, examined the homeostatic role of an enzyme, receptor activator of nuclear factor kappa-B (known as RANK), and two key modulators of its activity: RANK ligand (RANK-L) and osteoprotegrin...Study suggests morning pollution pall for Manchester commuters
... ... ... Analysis of all the data collected during the study is continuing, and the full re...Accumulator ring commissioning latest step for spallation neutron source
The Department of Energy's Spallation Neutron Source, located at Oak Ridge National Laboratory, has passed another milestone on the way to completion this year--the commissioning of the proton accumulator ring. The accumulator ring is the final step in a proton's journey through the accelerator before it strikes the SNS's mercury target, "spalling" away neutrons to be used for research.... ...The...Preparing for flu pandemic: Pall breathing filters can help protect patients, healthcare workers
East Hills, NY (Jan. 9, 2006) -- In the spring of 2003, the respiratory virus SARS traveled to five countries within 24 hours. Many of those who died were first responders principally Canadian and Taiwanese healthcare workers. SARS patients on ventilators infected the equipment, inadvertently exposing hospital staff and subsequent patients to the deadly virus. The same scenario looms for avia...Pall blood filtration technology removes prions that can cause TSEs
The study, entitled "Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter," published in the official journal of the AABB (Transfusion 2005; 45 (12): 1839-1844), shows that the filtration technology removes infectious scrapie prions. Scrapie is a TSE disease affecting sheep. The studies were conducted and authored by Samuel S...Pall filtration technology verified to remove arsenic from drinking water
East Hills, NY (Dec. 6, 2005) - - Municipal and community water providers are racing to meet the U.S. Environmental Protection Agency's (EPA) January 23, 2006 deadline for reducing arsenic in drinking water. The new ruling reduces the maximum allowable level of arsenic in drinking water to 10 parts per billion (ppb). Pall Corporation (NYSE: PLL) announced today that its membrane filtration tec...Pall tells FDA panel about blood filtering technology
East Hills, NY (Oct. 31, 2005) - - At the request of the Food and Drug Administration (FDA) Transmissible Spongiform Encephalopathies (TSEs) Advisory Committee, Pall Corporation (NYSE: PLL) today presented the latest research results on its prion technology to remove TSE infectivity from blood. The Pall LeukotrapR Affinity Prion Reduction Filter system is the only Council of Europe (CE) marked t...Pall Corporation presents approach for speeding vaccine production to Shanghai conference
East Hills, NY (October 28, 2005) - - As avian flu concerns extend across the globe, governments and pharmaceutical manufacturers face potentially huge demand for vaccines. According to public health experts, current production capacity and response times would not suffice in the event of a pandemic. Viral vaccine development is governed by stringent regulatory controls and can take as long as...Improved blood safety measures from Pall can increase platelet availability
East Hills, New York (Oct. 17, 2005) - - Availability of safe platelets is a fundamental blood transfusion challenge and can be especially problematic in times of emergency. Several studies presented at the annual AABB meeting today demonstrate new approaches to counteract platelet shortages by enhancing the safety of whole blood derived platelets, precluding the need to rely on only those obtai...Studies validating performance of Pall prion reduction technology presented at AABB
East Hills, NY (October 17, 2005) - - Research studies demonstrating the effectiveness of prion filtration technology to safeguard the blood supply are being presented at the AABB Annual Meeting in Seattle, Washington today. Prion diseases, such as variant Creutzfeldt-Jakob Disease (vCJD), the human form of Bovine Spongiform Encephalopathy or "mad cow" disease, are of growing concern to blood se...Breakthrough technology from Pall increases platelet availability and safety
East Hills, NY (October 5, 2005) -- Pall Corporation (NYSE: PLL) announced today FDA clearance to market the new Pall AcrodoseTM PL System. This is the first whole blood derived platelet system for pre-storage pooling and testing of leukoreduced whole blood derived platelets resulting in a transfusion-ready product for the hospital. This unique product increases the availability of lifesaving pla...Pall systems play key role in landmark NIH study on cord blood
East Hills, NY (August 17, 2005) -- As cord blood increasingly takes front and center stage as a critical source of stem cells for transplants, it has driven the need for consistent quality standards to ensure the safety and efficacy of this life-saving therapy. The newly published results of the landmark COBLT (Cord Blood Transplantation) Study advance standards for cord blood collection, proce...New results validating Pall prion reduction filter disclosed at ISBT Congress
Athens, Greece (July 4, 2005) -- Safety in transfusion medicine is an ongoing challenge to blood services worldwide as new threats, such as variant Creutzfeldt-Jakob Disease (vCJD), emerge. An update on the latest measures to protect the public from the human form of Bovine Spongiform Encephalopathy (BSE), commonly called Mad Cow Disease, and minimize risk of transmission through blood transfusi...Pall prion removal technology presented to FDA blood products advisory committee
East Hills, NY (March 17, 2005) -- An update on Transmissible Spongiform Encephalopathies (TSEs), including variant Creutzfeldt-Jakob Disease (vCJD), the human form of "mad cow" disease, was a key topic at the Food & Drug Administration's Blood Products Advisory Committee meeting in Gaithersburg, Maryland today. Issues such as the number of people that could be harboring vCJD as carriers, the imp...Pall-Aquasafe protects patients from exposure to waterborne contaminated medical equipment
East Hills, NY (Feb. 17, 2005)- - Hospital water is a significant source of microbial contamination contributing to the increase of nosocomial (hospital-acquired) infections worldwide, a leading cause of morbidity and mortality especially among immunocompromised patients. Healthcare regulators around the globe have issued guidelines, many specifying the use of 0.2 micron point-of use filters, to...